| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,664 |
6,009 |
$268K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,367 |
12,914 |
$208K |
| 80061 |
Lipid panel |
13,414 |
12,987 |
$167K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,775 |
5,585 |
$159K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,694 |
6,000 |
$157K |
| 80053 |
Comprehensive metabolic panel |
13,944 |
13,429 |
$136K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,440 |
15,516 |
$118K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,822 |
7,533 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,356 |
1,270 |
$68K |
| 36415 |
Collection of venous blood by venipuncture |
19,558 |
17,605 |
$49K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,802 |
1,747 |
$40K |
| 81001 |
|
12,439 |
11,810 |
$38K |
| 84153 |
|
1,915 |
1,848 |
$32K |
| 86738 |
|
2,448 |
2,280 |
$31K |
| 86328 |
|
1,250 |
1,199 |
$31K |
| 82274 |
|
1,992 |
1,926 |
$30K |
| 82607 |
|
1,933 |
1,845 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,343 |
1,196 |
$27K |
| 85027 |
|
4,628 |
4,280 |
$26K |
| 80074 |
|
581 |
556 |
$26K |
| 82043 |
|
4,171 |
3,971 |
$24K |
| 84436 |
|
3,248 |
3,147 |
$21K |
| 87276 |
|
1,659 |
1,529 |
$20K |
| 87088 |
|
2,690 |
2,586 |
$20K |
| 87275 |
|
1,644 |
1,523 |
$20K |
| 84479 |
|
3,187 |
3,089 |
$19K |
| 83970 |
|
464 |
432 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,228 |
2,123 |
$17K |
| 82378 |
|
959 |
907 |
$17K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
565 |
540 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
517 |
491 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,318 |
2,231 |
$16K |
| 84439 |
|
1,439 |
1,383 |
$13K |
| 81000 |
|
3,330 |
3,271 |
$11K |
| 86592 |
|
1,948 |
1,884 |
$8K |
| 85651 |
|
1,620 |
1,577 |
$5K |
| 82570 |
|
827 |
754 |
$4K |
| 86304 |
|
195 |
190 |
$4K |
| 82947 |
|
997 |
961 |
$3K |
| 82042 |
|
571 |
511 |
$3K |
| 85730 |
|
569 |
537 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
60 |
60 |
$3K |
| 87901 |
|
13 |
13 |
$3K |
| 86800 |
|
152 |
146 |
$2K |
| 85610 |
|
604 |
566 |
$2K |
| 82565 |
|
471 |
453 |
$2K |
| 82270 |
|
735 |
699 |
$2K |
| 86140 |
|
488 |
473 |
$2K |
| 82608 |
|
136 |
136 |
$2K |
| 86038 |
|
150 |
146 |
$2K |
| 82950 |
|
337 |
327 |
$1K |
| 84520 |
|
417 |
403 |
$1K |
| 83001 |
|
64 |
63 |
$1K |
| 82746 |
|
91 |
89 |
$1K |
| 82044 |
|
247 |
247 |
$979.87 |
| 86430 |
|
191 |
190 |
$913.13 |
| 86376 |
|
58 |
54 |
$828.54 |
| 86803 |
|
50 |
48 |
$671.78 |
| 80050 |
General health panel |
54 |
53 |
$527.21 |
| 87899 |
|
49 |
46 |
$517.12 |
| 83655 |
|
44 |
44 |
$500.94 |
| 84146 |
|
26 |
26 |
$490.48 |
| 84481 |
|
29 |
29 |
$450.28 |
| 84403 |
|
15 |
12 |
$379.36 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,510 |
1,265 |
$330.42 |
| 86361 |
|
13 |
13 |
$323.52 |
| 84702 |
|
13 |
13 |
$185.33 |
| 82465 |
|
39 |
37 |
$144.11 |
| 86709 |
|
14 |
14 |
$136.22 |
| 82951 |
|
12 |
12 |
$123.99 |
| 84550 |
|
27 |
27 |
$112.96 |
| 87070 |
|
12 |
12 |
$102.95 |
| 84703 |
|
12 |
12 |
$86.26 |
| 84478 |
|
14 |
14 |
$70.74 |